These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty. Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model. Higaki S; Watanabe K; Itahashi M; Shimomura Y Curr Eye Res; 2009 Mar; 34(3):171-6. PubMed ID: 19274523 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B. Blatt AN; Laycock KA; Brady RH; Traynor P; Krogstad DJ; Pepose JS Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3459-65. PubMed ID: 8225880 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection. Noisakran SJ; Carr DJ Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035 [TBL] [Abstract][Full Text] [Related]
8. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1. Itahashi M; Higaki S; Shimomura Y Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562 [TBL] [Abstract][Full Text] [Related]
9. A cAMP response element within the latency-associated transcript promoter of HSV-1 facilitates induced ocular reactivation in a mouse hyperthermia model. Marquart ME; Zheng X; Tran RK; Thompson HW; Bloom DC; Hill JM Virology; 2001 May; 284(1):62-9. PubMed ID: 11352668 [TBL] [Abstract][Full Text] [Related]
10. Iontophoresis of lysophosphatidic acid into rabbit cornea induces HSV-1 reactivation: evidence that neuronal signaling changes after infection. Martin RE; Loutsch JM; Garza HH; Boedeker DJ; Hill JM Mol Vis; 1999 Dec; 5():36. PubMed ID: 10617773 [TBL] [Abstract][Full Text] [Related]
11. Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus. Stroop WG; Schaefer DC Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):229-37. PubMed ID: 8591901 [TBL] [Abstract][Full Text] [Related]
12. Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1. Noisakran S; Halford WP; Veress L; Carr DJ J Immunol; 1998 Jun; 160(11):5441-7. PubMed ID: 9605146 [TBL] [Abstract][Full Text] [Related]
13. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice. Benencia F; Courrèges MC; Gamba G; Cavalieri H; Massouh EJ Invest Ophthalmol Vis Sci; 2001 May; 42(6):1277-84. PubMed ID: 11328740 [TBL] [Abstract][Full Text] [Related]
14. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation. LeBlanc RA; Pesnicak L; Godleski M; Straus SE Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356 [TBL] [Abstract][Full Text] [Related]
15. The effect of topical ocular corticosteroid administration in dogs with experimentally induced latent canine herpesvirus-1 infection. Ledbetter EC; Kice NC; Matusow RB; Dubovi EJ; Kim SG Exp Eye Res; 2010 Jun; 90(6):711-7. PubMed ID: 20223234 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits. Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329 [TBL] [Abstract][Full Text] [Related]